XGN
Exagen Inc
1 day chart
About XGN
Exagen Inc. is a commercial-stage life sciences company. The Company offers physicians testing and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. The Company develops and commercializes testing products under its AVISE brand. Its products include AVISE CTD, AVISE Lupus, AVISE APS, AVISE Vasculitis AAV, AVISE SLE Prognostic, AVISE Anti-CarP, AVISE PC4d, AVISE SLE Monitor, AVISE MTX and AVISE HCQ. Its lead testing product, AVISE CTD, enables differential diagnosis for patients presenting with symptoms indicative of a variety of connective tissue diseases (CTD) and other related diseases with overlapping symptoms. Its AVISE brand allows for the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis. Its product portfolio integrates CB-CAPs technology, which is a stable and reliable method for differentially diagnosing SLE.
Buy US stocks in Australia starting with XGN. Open an account and start investing today!
$39.96M
-
0.00%
15.86K
$2.51
$2.26
$2.32
$4.75
$2.04
XGN FAQs
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in XGN
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.